Sofinnova Investments, Inc. Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$1.1T
Holdings
71
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (71 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 1,109,874 | $106.9B | 9.67% | |
| 2 | NTRANatera | 3,100,560 | $101.7B | 9.20% | |
| 3 | AMRNAmarin | 5,208,305 | $79.0B | 7.14% | |
| 4 | NXTCNextcure, Inc | 2,521,856 | $77.8B | 7.03% | |
| 5 | YMABUSDY-mAbs Therapeutics, Inc | 2,104,278 | $54.8B | 4.96% | |
| 6 | —Spark Therapeutics | 481,270 | $46.7B | 4.22% | |
| 7 | —Principia Biopharma | 1,417,258 | $40.0B | 3.62% | |
| 8 | —ObsEva SA | 4,749,623 | $39.6B | 3.58% | |
| 9 | CHRSCoherus BioSciences | 1,933,221 | $39.2B | 3.54% | |
| 10 | MRUSMerus N.V. | 1,961,039 | $34.9B | 3.16% | |
| 11 | KRTXKaruna Therapeutics, Inc. | 1,729,352 | $28.2B | 2.55% | |
| 12 | —Health Care Select Sector SPDR | 300,000 | $27.0B | 2.44% | Put |
| 13 | —Audentes Therapeutics | 933,640 | $26.2B | 2.37% | |
| 14 | BMYBristol-Myers Squibb Co | 478,349 | $24.3B | 2.19% | |
| 15 | —Allergan plc | 134,433 | $22.6B | 2.05% | |
| 16 | VRTXVertex Pharmaceuticals Inc | 121,690 | $20.6B | 1.86% | |
| 17 | AMGNAmgen Inc | 92,300 | $17.9B | 1.61% | |
| 18 | —Nucana Biomed Ltd | 2,400,000 | $17.4B | 1.57% | |
| 19 | NBIXNeurocrine Biosciences Inc | 191,679 | $17.3B | 1.56% | |
| 20 | —Nucana Biomed Ltd | 2,266,666 | $16.4B | 1.48% | |
| 21 | XLRNAcceleron Pharma Inc | 408,262 | $16.1B | 1.46% | |
| 22 | UTHUnited Therapeutics Corp | 194,014 | $15.5B | 1.40% | |
| 23 | PFEPfizer Inc | 410,607 | $14.8B | 1.33% | |
| 24 | RETAEURReata Pharmaceuticals Inc | 148,669 | $11.9B | 1.08% | |
| 25 | —Reata Pharmaceuticals Inc | 148,600 | $11.9B | 1.08% | Put |
| 26 | ITRMIterum Therapeutics | 1,726,514 | $10.0B | 0.90% | |
| 27 | HALOHalozyme Therapeutics Inc | 636,167 | $9.9B | 0.89% | |
| 28 | TGTXTG Therapeutics Inc | 1,733,628 | $9.7B | 0.88% | |
| 29 | PTCTPTC Therapeutics Inc | 287,245 | $9.7B | 0.88% | |
| 30 | —Chiasma | 1,630,221 | $8.1B | 0.73% | |
| 31 | SRPTSarepta Therapeutics Inc | 106,414 | $8.0B | 0.72% | |
| 32 | KNSAKiniksa Pharmaceuticals, Ltd | 922,700 | $7.9B | 0.71% | |
| 33 | MGNXMacroGenics Inc | 581,554 | $7.4B | 0.67% | |
| 34 | —Aimmune Therapeutics Inc | 346,770 | $7.3B | 0.66% | |
| 35 | —Entasis Therapeutics Holdings Inc. | 1,180,178 | $7.0B | 0.64% | |
| 36 | —Kadmon Holdings Inc | 2,609,758 | $6.6B | 0.59% | |
| 37 | —Dermira Inc | 990,168 | $6.3B | 0.57% | |
| 38 | ONCBeigene Ltd | 50,000 | $6.1B | 0.55% | Call |
| 39 | —MyoKardia Inc | 113,926 | $5.9B | 0.54% | |
| 40 | FATEFate Therapeutics Inc | 381,600 | $5.9B | 0.54% | |
| 41 | AM6Amicus Therapeutics Inc | 722,974 | $5.8B | 0.52% | |
| 42 | BMRNBiomarin Pharmaceutical Inc | 84,896 | $5.7B | 0.52% | |
| 43 | —Dicerna Pharmaceuticals Inc | 342,755 | $4.9B | 0.45% | |
| 44 | AKBAAkebia Therapeutics Inc | 1,227,191 | $4.8B | 0.43% | |
| 45 | —Zymeworks Inc | 188,438 | $4.7B | 0.42% | |
| 46 | HRTXHeron Therapeutics Inc | 227,002 | $4.2B | 0.38% | Call |
| 47 | XBITXBiotech Inc | 358,663 | $3.8B | 0.34% | |
| 48 | —Foamix Pharmaceuticals Ltd | 1,199,254 | $3.6B | 0.33% | |
| 49 | OTICEUROtonomy Inc | 1,437,965 | $3.4B | 0.31% | |
| 50 | ORTXUSDOrchard Therapeutics PLC | 283,406 | $3.4B | 0.30% | |
| 51 | —Forty Seven Inc | 519,298 | $3.3B | 0.30% | |
| 52 | —Calithera Biosciences Inc | 964,852 | $3.0B | 0.27% | |
| 53 | —ArQule Inc | 393,387 | $2.8B | 0.25% | |
| 54 | FIXXEURHomology Medicines Inc | 146,297 | $2.6B | 0.24% | |
| 55 | CYTKCytokinetics Inc | 210,992 | $2.4B | 0.22% | |
| 56 | MRTXEURMirati Therapeutics Inc | 30,800 | $2.4B | 0.22% | |
| 57 | ACRSAclaris Therapeutics | 1,911,573 | $2.1B | 0.19% | |
| 58 | KALAKala Pharmaceuticals Inc | 478,206 | $1.8B | 0.16% | |
| 59 | SNDXSyndax Pharmaceuticals Inc | 243,150 | $1.8B | 0.16% | |
| 60 | AFWAlign Technology Inc | 10,000 | $1.8B | 0.16% | |
| 61 | —Portola Pharmaceuticals Inc | 59,191 | $1.6B | 0.14% | |
| 62 | APLTApplied Therapeutics Inc | 142,004 | $1.6B | 0.14% | |
| 63 | SNDXSyndax Pharmaceuticals Inc | 200,000 | $1.5B | 0.14% | Put |
| 64 | BCRXBioCryst Pharmaceuticals Inc | 516,734 | $1.5B | 0.13% | |
| 65 | YB4PSavara Inc | 527,318 | $1.4B | 0.13% | |
| 66 | —Synlogic Inc. | 574,972 | $1.3B | 0.12% | |
| 67 | APLSApellis Pharmaceuticals, Inc | 49,580 | $1.2B | 0.11% | |
| 68 | HRTXHeron Therapeutics Inc | 53,800 | $995.0M | 0.09% | Call |
| 69 | —Sunesis Pharmaceuticals Inc | 1,133,947 | $816.0M | 0.07% | |
| 70 | SNDXSyndax Pharmaceuticals Inc | 100,000 | $746.0M | 0.07% | Call |
| 71 | PDSBPDS Biotechnology Corporation | 142,635 | $482.0M | 0.04% |